High donor hemoglobin interacts with pre-transplant recipient neutropenia to modulate mortality after allogeneic hematopoietic stem cell transplantation: An exploratory, single-center, retrospective, real-world study
Mohammadreza Eslami, Mahdi Mehrabi, Mehrdad Payandeh · 2026
Read High donor hemoglobin interacts with pre-transplant recipient neutropenia to modulate mortality after allogeneic hematopoietic stem cell transplantation: An exploratory, single-center, retrospective, real-world study by Mohammadreza Eslami, Mahdi Mehrabi, Mehrdad Payandeh (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0349615.txt.
Description
Mohammadreza Eslami and colleagues looked back at ninety-four stem cell transplant patients in western Iran to see how donor and recipient blood traits jointly affected survival. Transplant doctors still struggle to predict who will do poorly years later. The team focused on two simple measures: the donor's hemoglobin level and whether the recipient had very low infection-fighting white cells before transplant.
Higher donor hemoglobin alone showed only a weak trend toward worse survival. The striking result was the interaction: the effect of donor hemoglobin depended on the recipient's white cell state before transplant. Because the study is small and exploratory, the authors treat it as a lead for larger studies, not a rule for choosing donors today.
Catalog record
| CREATOR | Mohammadreza Eslami, Mahdi Mehrabi, Mehrdad Payandeh |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38945 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |